FDA Cites Good Stuff Cacao in 2026-07-02 Warning Letter — New Drug/Misbranded
Letter issued · posted to fda.gov .
Subject as published: New Drug/Misbranded
TL;DR
Here's the summary: The FDA issued a warning letter to Good Stuff Cacao (Ms. Barbara J. Mietling, Co-Owner) on July 2, 2026 (CMS #729744) regarding labeling claims on its website for Goji Berries, Green Tea, Raw Cacao Powder, and Crystallized Raw Honey. The agency determined these products are unapproved new drugs under the Federal Food, Drug, and Cosmetic Act because product labels make disease-treatment claims (e.g., "Anti-Cancer," "Lowers Risk of Heart Disease," "Fights Tooth Decay," "Antiviral") without FDA approval, and some products lack adequate directions for safe use by laypersons for their intended purposes, rendering them misbranded. Good Stuff Cacao must respond within 15 working days with corrective actions or face potential seizure and injunction.
Argus analysis
# FDA Warning Letter Analysis: Good Stuff Cacao
**Company Background and Violations**
Good Stuff Cacao, a food and beverage company owned by Ms. Barbara J. Mietling in Rock Island, Tennessee, received a warning letter from the FDA's Human Foods Program on July 2, 2026 (CMS #729744). During an April 2026 website review, FDA investigators identified product claims that transformed four items—Goji Berries, Green Tea, Raw Cacao Powder, and Crystallized Raw Honey—into unapproved drugs under federal law. The company's labeling and website made disease-related claims including "Anti-Cancer," "Lowers Risk of Heart Disease," "Fights Alzheimer's," "Regulate Blood Sugar," and "Antiviral."
**Regulatory Citations and Meaning**
The warning cites section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act, which defines products intended to cure, mitigate, treat, or prevent disease as drugs—regardless of their natural origins. The letter references section 201(p), establishing these as "new drugs" lacking required FDA approval. Additionally, section 502(f)(1) and 21 C.F.R. § 201.5 address misbranding: drugs treating conditions requiring professional supervision cannot bear adequate directions for consumer use, making them inherently misbranded. Section 301(a) prohibits introducing such violative products into interstate commerce.
**Response Timeline and Industry Implications**
Good Stuff Cacao has 15 working days to submit written corrective actions to HFP-OCE-Labeling@fda.hhs.gov and compliance officer Simone E. Hollis. The company must explain preventive measures and provide supporting documentation, or justify any delays. Peer compliance officers monitoring this case should expect FDA enforcement escalation if the response proves inadequate, potentially including seizure or injunction. Similar food companies making disease claims should conduct immediate labeling audits and revise marketing materials accordingly.
Severity context
Critical severity. Typically reserved for data integrity, sterile-product CGMP, or repeat violations — matters that historically precede injunctions, consent decrees, or import alerts.
Regulatory background
Labeling letters cite 21 USC 343 (food), 21 USC 352 (drugs), or 21 USC 352 (devices). Most are resolved by SKU-level copy revision within the 15-business-day response window.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER Good Stuff Cacao MARCS-CMS 729744 — July 02, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email with Confirmation of Receipt Product: Food & Beverages Recipient: Recipient Name Ms. Barbara J. Mietling Recipient Title Co-Owner Good Stuff Cacao 631 Hideaway Ln Rock Island , TN 38581-4246 United States (b)(6), (b)(7)(C) Issuing Office: Human Foods Program United States WARNING LETTER July 2, 2026 CMS # 729744 Dear Ms. Mietling: The United States Food and Drug Administration (FDA) reviewed your website at the Internet address https://goodstuffcacao.com in April 2026 and determined that you take orders there for your Goji Berries, Green Tea, Raw Cacao Powder, and Crystalized Raw Honey products. The claims on your website, https://goodstuffcacao.com, establish that these products are drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or prevention of disease. As explained further below, introducing or delivering these products for introduction into interstate commerce for such uses violates the Act. You can find the Act and FDA regulations through links on FDA’s home page at www.fda.gov. Examples of some of the claims that provide evidence that your products are intended for use as drugs include: On your website for Goji Berries, https://goodstuffcacao.com/products/goji-berry?_pos=1&_sid=4b101b33a&_ss=r, an image of your product label includes the following statements: "Anti-Cancer" "Anti-Diabetic" "Antimicrobial" On your website for Green Tea, https://goodstuffcacao.com/products/green-tea?_pos=1&_sid=ac5debabb&_ss=r, an image of your product label includes the following statements: "Lowers Risk of Heart Disease" "Fights Alzheimer's, Parkinson's and More" "Reduces Anxiety" On your website for Raw Cacao Powder, https://goodstuffcacao.com/products/raw-cacao-powder?_pos=1&_sid=f79053364&_ss=r, an image of your product label includes the following statements: "Fights Tooth Decay" "Regulate Blood Sugar" "Lower Blood Pressure" On your website for Crystallized Raw Honey, https://goodstuffcacao.com/products/crystalized-raw-honey?_pos=1&_sid=519622a80&_ss=r, an image of your product label includes the following statement: "Antiviral" Your Goji Berries, Green Tea, Raw Cacao Powder, and Crystalized Raw Honey are not generally recognized as safe and effective for the above referenced uses and, therefore, these products are “new drugs” under section 201(p) of the Act [21 U.S.C. § 321(p)]. With certain exceptions not applicable here, new drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in sections 301(d) and 505(a) of the Act [21 U.S.C. §§ 331(d), 355(a)]. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. Misbra…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- When did FDA issue the warning letter to Good Stuff Cacao?
- FDA issued the letter (MARCS-CMS 729744) on 2026-07-02 and posted it publicly on fda.gov on 2026-09-29.
- Is the FDA warning letter to Good Stuff Cacao publicly available?
- Yes. The full verbatim letter is published at fda.gov. Argus HQ links directly to the source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/good-stuff-cacao-729744-07022026.
- What does a "critical" severity rating mean for this letter?
- Critical severity. Typically reserved for data integrity, sterile-product CGMP, or repeat violations — matters that historically precede injunctions, consent decrees, or import alerts.
- What is the regulatory background for a Labeling / misbranded warning letter?
- Labeling letters cite 21 USC 343 (food), 21 USC 352 (drugs), or 21 USC 352 (devices). Most are resolved by SKU-level copy revision within the 15-business-day response window.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Cites Good Stuff Cacao in 2026-07-02 Warning Letter — New Drug/Misbranded. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-good-stuff-cacao-2026-07-02-labeling
"FDA Cites Good Stuff Cacao in 2026-07-02 Warning Letter — New Drug/Misbranded." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-good-stuff-cacao-2026-07-02-labeling.
Argus HQ Research. "FDA Cites Good Stuff Cacao in 2026-07-02 Warning Letter — New Drug/Misbranded." Digital Empire Holdings LLC. Accessed September 30, 2026. https://argushq.ai/fda/warning-letter/fda-wl-good-stuff-cacao-2026-07-02-labeling.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_good_stuff_cacao_2026_07_02_labeling_2026,
title = {FDA Cites Good Stuff Cacao in 2026-07-02 Warning Letter — New Drug/Misbranded},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-good-stuff-cacao-2026-07-02-labeling},
note = {Accessed: September 30, 2026}
}